Interim Results from Phase Ib/II CLASSICAL-Lung Study Show Promise in NSCLC

Updated interim results from the phase Ib/II CLASSICAL-Lung study showed promise for pepinemab in combination with avelumab in patients with advanced stage non-small cell lung cancer.

Source: CancerNetwork - April 28, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news